Lupin Can't Escape Gilead's Ranexa Patent Suit
A New Jersey federal judge on Thursday refused generic-drug maker Lupin Ltd.'s request to boot a patent infringement suit brought by Gilead Sciences Inc. over its chest pain drug Ranexa, rejecting...To view the full article, register now.
Already a subscriber? Click here to view full article